What is Customedica?
Customedica operates as a specialized pharmacy provider with a focus on bespoke compounded medications alongside traditional retail pharmaceutical services. Based in Eagle and Boise, the firm distinguishes itself through a high-touch, consultative model that addresses niche health requirements, including hormone replacement therapy, women's and men's health, and veterinary medicine. By integrating modern retail conveniences like car-side concierge services and digital refill management, Customedica bridges the gap between personalized clinical care and accessible pharmacy retail. The company's market position is defined by its commitment to precision and patient-centric care, catering to a demographic that demands tailored therapeutic solutions beyond standard off-the-shelf offerings.
How much funding has Customedica raised?
Customedica has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Customedica
PPP
Public-Private Partnership
What's next for Customedica?
With the recent influx of capital, Customedica is poised to scale its compounding capabilities and potentially broaden its geographic presence. The late-stage funding context suggests a transition toward optimizing supply chain efficiencies and investing in advanced laboratory technologies to meet the rising demand for customized health solutions. Future growth strategies will likely prioritize the integration of digital health platforms to streamline patient consultations and improve medication adherence. As the pharmacy sector continues to evolve toward personalized medicine, Customedica's focus on specialized care provides a robust foundation for long-term value creation and market differentiation in the regional healthcare ecosystem.
See full Customedica company page
